Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2019

01-05-2019 | Original Article

Treatment history and association between allergic rhinitis symptoms and quality of life

Authors: Marlene M. Speth, Lloyd P. Hoehle, Katie M. Phillips, David S. Caradonna, Stacey T. Gray, Ahmad R. Sedaghat

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2019

Login to get access

Abstract

Background

Recalcitrance of allergic rhinitis (AR) to medical management may be reflective of patient-specific impact of AR symptoms.

Aims

To understand the relationship between AR symptoms and general health-related quality of life (QOL) or AR control, based on treatment status.

Methods

Cross-sectional cohort study of 130 adult participants—65 using no allergy medications and 65 consistently using intranasal corticosteroid sprays (ICS) in the last 3 months—presenting with persistent AR. General health-related QOL was measured using the EuroQol 5-dimensional visual analog scale (EQ-5D VAS). Severity and control of AR symptoms were measured using the 22-item Sinonasal Outcome Test (SNOT-22) and the Rhinitis Control Assessment Test (RCAT), respectively. We compared associations between AR symptoms and general health-related QOL and AR control in patients presenting with persistent AR with and without ICS use.

Results

Severity of AR symptoms was similar between cohorts. In participants using no allergy medications, extranasal AR symptom severities were most dominantly associated with decreased EQ-5D VAS and RCAT score. In participants using ICS, only nasal symptom severities were associated with decreased EQ-5D VAS and RCAT scores. Consistently, only in participants on ICS was a deviated septum associated with decreased EQ-5D VAS (β = − 12.1, 95% CI − 21.1 to − 3.1, p = 0.011) and poorly controlled AR (OR = 4.27, 96% CI 1.27 to 14.33; p = 0.019).

Conclusions

In persistent AR despite consistent ICS use, nasal symptoms may be the dominant drivers of AR-associated decreased general health-related QOL in contrast to persistent AR on no medication, when extranasal symptoms of AR are most significant. Longitudinal study is needed to investigate whether these results are predictive of responsiveness to ICS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bousquet J, Khaltaev N, Cruz AA et al (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(Suppl 86):8–160CrossRefPubMed Bousquet J, Khaltaev N, Cruz AA et al (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(Suppl 86):8–160CrossRefPubMed
2.
go back to reference Hellgren J, Cervin A, Nordling S et al (2010) Allergic rhinitis and the common cold—high cost to society. Allergy 65(6):776–783CrossRefPubMed Hellgren J, Cervin A, Nordling S et al (2010) Allergic rhinitis and the common cold—high cost to society. Allergy 65(6):776–783CrossRefPubMed
3.
go back to reference Price D, Scadding G, Ryan D et al (2015) The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clin Transl Allergy 5:6 eCollection 2015CrossRef Price D, Scadding G, Ryan D et al (2015) The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clin Transl Allergy 5:6 eCollection 2015CrossRef
5.
go back to reference Canonica GW, Bousquet J, Mullol J et al (2007) A survey of the burden of allergic rhinitis in Europe. Allergy 62(Suppl 85):17–25CrossRefPubMed Canonica GW, Bousquet J, Mullol J et al (2007) A survey of the burden of allergic rhinitis in Europe. Allergy 62(Suppl 85):17–25CrossRefPubMed
6.
go back to reference Bauchau V, Durham SR (2004) Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 24(5):758–764CrossRefPubMed Bauchau V, Durham SR (2004) Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 24(5):758–764CrossRefPubMed
7.
go back to reference Seidman MD, Gurgel RK, Lin SY et al (2015) Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg 152(1 Suppl):1CrossRef Seidman MD, Gurgel RK, Lin SY et al (2015) Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg 152(1 Suppl):1CrossRef
8.
go back to reference Jordana G, Dolovich J, Briscoe MP et al (1996) Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 97(2):588–595CrossRefPubMed Jordana G, Dolovich J, Briscoe MP et al (1996) Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 97(2):588–595CrossRefPubMed
9.
go back to reference Sedaghat AR, Busaba NY, Cunningham MJ et al (2013 Jan) Clinical assessment is an accurate predictor of which patients will need septoplasty. Laryngoscope 123(1):48–52CrossRefPubMed Sedaghat AR, Busaba NY, Cunningham MJ et al (2013 Jan) Clinical assessment is an accurate predictor of which patients will need septoplasty. Laryngoscope 123(1):48–52CrossRefPubMed
10.
go back to reference Blaiss MS, Benninger MS, Fromer L et al (2006) Expanding choices in intranasal steroid therapy: summary of a roundtable meeting. Allergy Asthma Proc 27(3):254–264CrossRefPubMed Blaiss MS, Benninger MS, Fromer L et al (2006) Expanding choices in intranasal steroid therapy: summary of a roundtable meeting. Allergy Asthma Proc 27(3):254–264CrossRefPubMed
11.
go back to reference Hoehle LP, Speth MM, Phillips KM et al (2017) Association between symptoms of allergic rhinitis with decreased general health-related quality of life. Am J Rhinol Allergy 31(4):235–239CrossRefPubMed Hoehle LP, Speth MM, Phillips KM et al (2017) Association between symptoms of allergic rhinitis with decreased general health-related quality of life. Am J Rhinol Allergy 31(4):235–239CrossRefPubMed
12.
go back to reference Blaiss MS, Dykewicz MS, Skoner DP et al (2014) Diagnosis and treatment of nasal and ocular allergies: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys. Ann Allergy Asthma Immunol 112(4):8.e1CrossRef Blaiss MS, Dykewicz MS, Skoner DP et al (2014) Diagnosis and treatment of nasal and ocular allergies: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys. Ann Allergy Asthma Immunol 112(4):8.e1CrossRef
13.
go back to reference Schatz M, Meltzer EO, Nathan R et al (2010) Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control. Ann Allergy Asthma Immunol 104(2):118–124CrossRefPubMed Schatz M, Meltzer EO, Nathan R et al (2010) Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control. Ann Allergy Asthma Immunol 104(2):118–124CrossRefPubMed
14.
go back to reference Pynnonen MA, Kim HM, Terrell JE (2009) Validation of the Sino-Nasal Outcome Test 20 (SNOT-20) domains in nonsurgical patients. Am J Rhinol Allergy 23(1):40–45CrossRefPubMed Pynnonen MA, Kim HM, Terrell JE (2009) Validation of the Sino-Nasal Outcome Test 20 (SNOT-20) domains in nonsurgical patients. Am J Rhinol Allergy 23(1):40–45CrossRefPubMed
15.
go back to reference EuroQol Group (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16(3):199–208CrossRef EuroQol Group (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16(3):199–208CrossRef
16.
go back to reference R Development Core Team (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna R Development Core Team (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
17.
go back to reference Bousquet PJ, Demoly P, Devillier P et al (2013) Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol 160(4):393–400CrossRefPubMed Bousquet PJ, Demoly P, Devillier P et al (2013) Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol 160(4):393–400CrossRefPubMed
18.
go back to reference Bousquet PJ, Bachert C, Canonica GW et al (2010) Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. J Allergy Clin Immunol 126(3):5CrossRef Bousquet PJ, Bachert C, Canonica GW et al (2010) Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. J Allergy Clin Immunol 126(3):5CrossRef
19.
go back to reference Virchow JC, Kay S, Demoly P et al (2011) Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients—an observational, cross sectional study in four countries in Europe. J Med Econ 14(3):305–314CrossRefPubMed Virchow JC, Kay S, Demoly P et al (2011) Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients—an observational, cross sectional study in four countries in Europe. J Med Econ 14(3):305–314CrossRefPubMed
20.
go back to reference Hiraki N, Suzuki H, Udaka T et al (2008) Snoring, daytime sleepiness, and nasal obstruction with or without allergic rhinitis. Arch Otolaryngol Head Neck Surg 134(12):1254–1257CrossRefPubMed Hiraki N, Suzuki H, Udaka T et al (2008) Snoring, daytime sleepiness, and nasal obstruction with or without allergic rhinitis. Arch Otolaryngol Head Neck Surg 134(12):1254–1257CrossRefPubMed
21.
go back to reference Skoner AR, Skoner KR, Skoner DP (2009) Allergic rhinitis, histamine, and otitis media. Allergy Asthma Proc 30(5):470–481CrossRefPubMed Skoner AR, Skoner KR, Skoner DP (2009) Allergic rhinitis, histamine, and otitis media. Allergy Asthma Proc 30(5):470–481CrossRefPubMed
22.
go back to reference Wallace DV, Dykewicz MS, Bernstein DI et al (2008) The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 122(2 Suppl):1CrossRef Wallace DV, Dykewicz MS, Bernstein DI et al (2008) The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 122(2 Suppl):1CrossRef
23.
go back to reference Kaszuba SM, Baroody FM, deTineo M et al (2001) Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med 161(21):2581–2587CrossRefPubMed Kaszuba SM, Baroody FM, deTineo M et al (2001) Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med 161(21):2581–2587CrossRefPubMed
Metadata
Title
Treatment history and association between allergic rhinitis symptoms and quality of life
Authors
Marlene M. Speth
Lloyd P. Hoehle
Katie M. Phillips
David S. Caradonna
Stacey T. Gray
Ahmad R. Sedaghat
Publication date
01-05-2019
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2019
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-018-1866-2

Other articles of this Issue 2/2019

Irish Journal of Medical Science (1971 -) 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.